GSK plans graduated approach to drug patents to help poor
LONDON (Reuters) - GlaxoSmithKline said on Thursday it would adopt a graduated approach to patenting its medicines, depending on the wealth of different countries, in order to make drugs more affordable in the developing world.
Aucun commentaire:
Enregistrer un commentaire